1.Intervention of Acute Lung Injury by Traditional Chinese Medicine via Regulating Oxidative Stress: A Review
Ang'ang LI ; Xiao LIANG ; Junmei LI ; Qing PENG ; Jianxun LIU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(10):305-312
Acute lung injury (ALI) is a clinically critical disease with limited treatment options and poor prognosis, with high morbidity and mortality. Pulmonary inflammation caused by trauma, infection, and other factors in vivo and in vitro can damage alveolar epithelial and vascular endothelial barriers, resulting in lung tissue congestion and edema and eventually leading to significant dyspnea and hypoxemia, It can further develop into acute respiratory distress syndrome. Oxidative stress is one of the pathogenesis of ALI. A large number of reactive oxygen species (ROS) can promote the aggregation of inflammatory cells, increase pulmonary capillary permeability, and even directly damage lung tissue. Therefore, regulating oxidative stress becomes one of the effective means to reduce the degree of lung injury. According to the theory of traditional Chinese medicine (TCM), ALI is divided into the categories of "sudden wheezing" and "dyspnea due to wheezing". TCM treats the causes of dampness, heat, poison, and stasis by syndrome differentiation and treatment, regulates Qi and blood, and balances Yin and Yang to restore the physiological function of the lung. In recent years, a large number of studies have shown that TCM can regulate ROS through multiple targets and mechanisms and play a role in reducing lung inflammation and protecting alveolar epithelial cells and endothelial vessels, in which the nuclear factor E2 associated factor 2 (Nrf2) antioxidant pathway plays an important role. Based on the generation and clearance of ROS, this article summarized the related mechanisms of TCM monomers, TCM pairs, and TCM compounds in regulating oxidative stress to prevent ALI, so as to provide theoretical reference for the research and development of new TCM for ALI and clinical treatment.
6.MondoA Is Required for Normal Myogenesis and Regulation of the Skeletal Muscle Glycogen Content in Mice
Hui RAN ; Yao LU ; Qi ZHANG ; Qiuyue HU ; Junmei ZHAO ; Kai WANG ; Xuemei TONG ; Qing SU
Diabetes & Metabolism Journal 2021;45(3):439-451
Skeletal muscle is the largest tissue in the human body, and it plays a major role in exerting force and maintaining metabolism homeostasis. The role of muscle transcription factors in the regulation of metabolism is not fully understood. MondoA is a glucose-sensing transcription factor that is highly expressed in skeletal muscle. Previous studies suggest that MondoA can influence systemic metabolism homeostasis. However, the function of MondoA in the skeletal muscle remains unclear. We generated muscle-specific MondoA knockout (MAKO) mice and analyzed the skeletal muscle morphology and glycogen content. Along with skeletal muscle from MAKO mice, C2C12 myocytes transfected with small interfering RNA against MondoA were also used to investigate the role and potential mechanism of MondoA in the development and glycogen metabolism of skeletal muscle. MAKO caused muscle fiber atrophy, reduced the proportion of type II fibers compared to type I fibers, and increased the muscle glycogen level. MondoA knockdown inhibited myoblast proliferation, migration, and differentiation by inhibiting the phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway. Further mechanistic experiments revealed that the increased muscle glycogen in MAKO mice was caused by thioredoxin-interacting protein (TXNIP) downregulation, which led to upregulation of glucose transporter 4 (GLUT4), potentially increasing glucose uptake. MondoA appears to mediate mouse myofiber development, and MondoA decreases the muscle glycogen level. The findings indicate the potential function of MondoA in skeletal muscle, linking the glucose-related transcription factor to myogenesis and skeletal myofiber glycogen metabolism.
8.MondoA Is Required for Normal Myogenesis and Regulation of the Skeletal Muscle Glycogen Content in Mice
Hui RAN ; Yao LU ; Qi ZHANG ; Qiuyue HU ; Junmei ZHAO ; Kai WANG ; Xuemei TONG ; Qing SU
Diabetes & Metabolism Journal 2021;45(3):439-451
Skeletal muscle is the largest tissue in the human body, and it plays a major role in exerting force and maintaining metabolism homeostasis. The role of muscle transcription factors in the regulation of metabolism is not fully understood. MondoA is a glucose-sensing transcription factor that is highly expressed in skeletal muscle. Previous studies suggest that MondoA can influence systemic metabolism homeostasis. However, the function of MondoA in the skeletal muscle remains unclear. We generated muscle-specific MondoA knockout (MAKO) mice and analyzed the skeletal muscle morphology and glycogen content. Along with skeletal muscle from MAKO mice, C2C12 myocytes transfected with small interfering RNA against MondoA were also used to investigate the role and potential mechanism of MondoA in the development and glycogen metabolism of skeletal muscle. MAKO caused muscle fiber atrophy, reduced the proportion of type II fibers compared to type I fibers, and increased the muscle glycogen level. MondoA knockdown inhibited myoblast proliferation, migration, and differentiation by inhibiting the phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway. Further mechanistic experiments revealed that the increased muscle glycogen in MAKO mice was caused by thioredoxin-interacting protein (TXNIP) downregulation, which led to upregulation of glucose transporter 4 (GLUT4), potentially increasing glucose uptake. MondoA appears to mediate mouse myofiber development, and MondoA decreases the muscle glycogen level. The findings indicate the potential function of MondoA in skeletal muscle, linking the glucose-related transcription factor to myogenesis and skeletal myofiber glycogen metabolism.
10.Limb remote ischemic preconditioning attenuates liver ischemia reperfusion injury by activating autophagy via modulating PPAR-γ pathway.
Wei RUAN ; Qing LIU ; Chan CHEN ; Suobei LI ; Junmei XU
Journal of Central South University(Medical Sciences) 2016;41(9):918-928
OBJECTIVE:
To investigate the effect of limb remote ischemic preconditioning (RIPC) on hepatic ischemia/reperfusion (IR) injury and the underlying mechanisms.
METHODS:
Rats were subjected to partial hepatic IR (60 min ischemia followed by 24 hours reperfusion) with or without RIPC, which was achieved by 3 cycles of 10 min-occlusion and 10 min-
reperfusion at the bilateral femoral arteries interval 30 min before ischemia. Some rats were treated with a new PPAR-γ inhibitor, T0070907, before RIPC.
RESULTS:
At the end of reperfusion, liver injury was significantly increased (increases in Suzike's injury score, AST and ALT release), concomitant with elevated oxidative stress (increases in MDA formation, MPO activity, as well as the decrease in SOD activity) and inflammation (increases in TNF-α and IL-6 levels, decrease in IL-10 content). RIPC improved liver function and reduced histologic damage, accompanied by the increased PPAR-γ activation and autophagosome formation as well as the reduced autophagosome clearance. The beneficial effects of RIPC were markedly attenuated by T0070907, an inhibitor of PPAR-γ.
CONCLUSION
RIPC exerts the protective effects on liver by activation of autophagy via PPAR-γ.
Animals
;
Autophagy
;
drug effects
;
genetics
;
physiology
;
Extremities
;
Interleukin-10
;
metabolism
;
Interleukin-6
;
metabolism
;
Ischemia
;
Ischemic Preconditioning
;
methods
;
Liver
;
injuries
;
Liver Diseases
;
prevention & control
;
Oxidative Stress
;
drug effects
;
PPAR gamma
;
antagonists & inhibitors
;
Rats
;
Reperfusion Injury
;
prevention & control
;
Tumor Necrosis Factor-alpha
;
metabolism

Result Analysis
Print
Save
E-mail